|
Registro Completo |
|
Biblioteca(s): |
Embrapa Pecuária Sudeste. |
|
Data corrente: |
10/08/2007 |
|
Data da última atualização: |
23/06/2023 |
|
Tipo da produção científica: |
Artigo em Anais de Congresso / Nota Técnica |
|
Autoria: |
ZAFALON, L. F.; NADER FILHO, A.; MATARAZZO, S. V. |
|
Afiliação: |
LUIZ FRANCISCO ZAFALON, CPPSE; A. NADER FILHO, UNESP - FCA V, Jaboticabal, SP.; SORAIA VANESSA MATARAZZO, Instituto de Zootecnia - IZ, Nova Odessa, SP. |
|
Título: |
Subclinical mastitis caused by staphylococcus aureus: analysis cost benefit of antibiotic therapy in lactating. |
|
Ano de publicação: |
2007 |
|
Fonte/Imprenta: |
In: INTERNATIONAL DAIRY HOUSING CONFERENCE, 6., 2007, Mineapolis, USA. Proceedings... Mineapolis: ASABE, 2007 |
|
Idioma: |
Inglês |
|
Conteúdo: |
The cost benefit analysis of treatment ofbovine subclinical mastitis caused by S. aureus was evaluated. Two hundred and seventy udder quarters with subclinical mastitis and healthy were selected in four groups, in conformity to lactational slage and Wilh lhe trealment or noto Group I included lreated animais 10 to 60 days in milk; group 2 included trealed animais 61 days in milk untilrwo monlhs before lhe end oflactation; group 3 included animais not lreated 10 to 60 days in milk; group 4 included animais not lrealed from 61 days in milk unlil two monlhs before lhe end of lactalion. Trealment wilh gentamicin (150 mgi was accomplished by inlramammary doses, once a day, after sensitivity tests. The mammary quarters were evaluated after 30 days again. The costs with lhe treatment were calculaled considering a S. aureus prevalence of 5%, expenses with anlibiotic, loss in milk, lests of sensitivity and workload. There was loss of income of 2% and 14% in lhe groups I and 2, respeclively, when compared Wilh lhe incomes before trealment. In such case, the trealment of bovine subclinical maslilis by s. aurcus in lhe laclalion was economical/y nol practicable. |
|
Palavras-Chave: |
Antibiatic; costs; Subclinical maslitis; Treatmenl. |
|
Thesagro: |
Staphylococcus Aureus. |
|
Categoria do assunto: |
H Saúde e Patologia |
|
Marc: |
LEADER 01830nam a2200193 a 4500
001 1048018
005 2023-06-23
008 2007 bl uuuu u00u1 u #d
100 1 $aZAFALON, L. F.
245 $aSubclinical mastitis caused by staphylococcus aureus$banalysis cost benefit of antibiotic therapy in lactating.$h[electronic resource]
260 $aIn: INTERNATIONAL DAIRY HOUSING CONFERENCE, 6., 2007, Mineapolis, USA. Proceedings... Mineapolis: ASABE$c2007
520 $aThe cost benefit analysis of treatment ofbovine subclinical mastitis caused by S. aureus was evaluated. Two hundred and seventy udder quarters with subclinical mastitis and healthy were selected in four groups, in conformity to lactational slage and Wilh lhe trealment or noto Group I included lreated animais 10 to 60 days in milk; group 2 included trealed animais 61 days in milk untilrwo monlhs before lhe end oflactation; group 3 included animais not lreated 10 to 60 days in milk; group 4 included animais not lrealed from 61 days in milk unlil two monlhs before lhe end of lactalion. Trealment wilh gentamicin (150 mgi was accomplished by inlramammary doses, once a day, after sensitivity tests. The mammary quarters were evaluated after 30 days again. The costs with lhe treatment were calculaled considering a S. aureus prevalence of 5%, expenses with anlibiotic, loss in milk, lests of sensitivity and workload. There was loss of income of 2% and 14% in lhe groups I and 2, respeclively, when compared Wilh lhe incomes before trealment. In such case, the trealment of bovine subclinical maslilis by s. aurcus in lhe laclalion was economical/y nol practicable.
650 $aStaphylococcus Aureus
653 $aAntibiatic
653 $acosts
653 $aSubclinical maslitis
653 $aTreatmenl
700 1 $aNADER FILHO, A.
700 1 $aMATARAZZO, S. V.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Pecuária Sudeste (CPPSE) |
|
